In this project, the investigators will test the hypothesis that predominant (two to three times a week 60 min) strength training is more effective in reducing visceral fat mass than endurance training in obese patients.
Strength training (ST) was shown to be more effective than endurance training (ET) in improving glycemic control in the treatment of type 2 diabetes. However, it is unknown, whether different training strategies have different effects on the preferential visceral adipose tissue reduction and changes in resting energy expenditure in a population with abdominal obesity. We will therefore compare ST and ET (two to three times a week, 60 minutes per training session) in addition to a restricted energy intake of 1500kcal per day for women and 1800kcal per day for men in a prospective study of 200 individuals with abdominal obesity defined by a waist circumference \> 102 cm for males and \> 88 cm for females and a BMI \> 35 kg/m² with regard to: 1. Abdominal visceral adipose tissue area dynamic (MRI studies) 2. Abdominal subcutaneous adipose tissue area dynamic (MRI studies) 3. Total body fat mass changes (bioelectrical impedance analysis) 4. Changes in resting energy expenditure (indirect calorimetry) 5. Changes in parameters of glucose metabolism, insulin sensitivity and lipid profile 6. Changes in circulating adipokines and markers of inflammation In addition, we will search for novel serum parameters, which predict the individual training response by a serum metabolomics/ proteomics approach.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
comparison of strength versus endurance training (two or three times a week, 60 minutes per training session) over 24 months
University of Leipzig, Department of Medicine
Leipzig, Saxony, Germany
RECRUITINGMRI
Change from Baseline in abdominal visceral fat area as determined by MRI scans at the level of L4-L5 after 12 months of training intervention
Time frame: Baseline and after 12 months after randomisation
MRI
Changes from Baseline in abdominal visceral and subcutaneous fat area
Time frame: Baseline, 12 and 24 months after randomisation
BIA
Changes from Baseline in total body fat mass
Time frame: Baseline, 6, 12, 18 and 24 months after randomisation
compliance to the intervention
compliance to the intervention of training (strength or endurance) as measured by the number of realized training units. Non-compliance = cumulative time bigger than six weeks per year
Time frame: over 24 months of intervention
well being as measured by SF-36
Changes from Baseline in individual well being as measured by SF-36
Time frame: Baseline and every 6 months during intervention
indirect calorimetry
Changes from Baseline in resting energy expenditure
Time frame: Baseline, 6, 12, 18 and 24 months after randomisation
fasting plasma glucose
Changes from Baseline in fasting plasma glucose, insulin sensitivity and insulin secretion determined in oral glucose tolerance tests
Time frame: Baseline and every 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
inflammatory parameters
Changes from Baseline in inflammatory parameters
Time frame: Baseline and every 3 months during intervention
adipokine serum concentrations
Changes from Baseline in adipokine serum concentrations
Time frame: Baseline and every 3 months during intervention